Health, Economic Impact of COVID-19 Set to Lessen in Coming Years
Health care use projected to normalize after decline in 2020; remaining federal supplemental spending expected to decrease through 2024
Living-Donor Liver Transplant Promising for CRC With Liver Mets
Recurrence-free survival of 62 percent, overall survival of 100 percent at 1.5 years after LDLT in select patients
Early Use of COVID-19 Convalescent Plasma Cuts Hospitalization Risk
Administration of convalescent plasma within nine days after symptom onset can reduce risk of COVID-19-linked hospitalization
Stage Shift Seen With CT Screening for Lung Cancer in the U.S.
Stage shift toward Stage I NSCLC observed following introduction of low-dose CT screening for lung cancer
Probability of False-Positives Lower With Digital Breast Tomosynthesis
Cumulative probabilities of false-positive results substantially lower for biennial versus annual screening, regardless of modality
Global Burden of Melanoma Considerable, Set to Rise by 2040
If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040
Cancer Survivors Face Transportation Barriers to Accessing Care
Survivors who are younger, poor, uninsured or publicly insured, unmarried, or who have functional limitations have greatest barriers
Out-of-State Residents Can Now Seek Medical Aid in Dying in Oregon
Lawsuit that challenged the residency requirement as unconstitutional was settled Monday
Risks for Anaphylaxis Compared Among IV Iron Products
Rates of anaphylaxis low for IV iron products, but risk for anaphylaxis increased with iron dextran and ferumoxytol compared with iron sucrose
Risk for Ischemic Stroke Up With Antidopaminergic Antiemetic Use
Increase in risk greatest for metopimazine and metoclopramide; risk for ischemic stroke may be higher in first days of use
